Why the Bellamy's share price was down 68% since it's all-time highs

The Bellamy's Australia Ltd (ASX: BAL) share price has fallen 68% since its all-time high. Here are 2 reasons why…

a woman

The Bellamy's Australia Ltd (ASX: BAL) share price has fallen from $22.52 on 23 March, to as low as $7.18 in recent weeks, representing a 68% decline in the share price since its all-time high. Bellamy's falling share price follows weak year-on-year sales growth from the company. Two factors impacting on revenue growth are:

  • the unexpected delay in gaining Chinese export accreditation; and
  • China-United States trade war concerns.

SAMR accreditation

The State Administration for Market Regulation (SAMR) is China's new market regulator. It is designed to eliminate the duplication of work and streamline regulation. Bellamy's requires accreditation in order to export Chinese-labelled products directly into China. The past share price appreciation of Bellamy's and competitor A2 Milk Company Ltd (ASX: A2M) was strongly linked to the ability of the companies to target the large and growing Chinese market. Given that the SAMR aims to streamline regulation, Bellamy's should receive accreditation and revenue growth should return.

Management expects to grow revenue from $329 million in FY18 to $500 million by FY21.

China-United States trade war

One of the few things economists can agree on is that protection and trade barriers have a negative impact on an economy. As a result, the ongoing trade war between the United States and China has negatively impacted the share price of Australian companies that make money in China. The current truce between President Trump and President Xi is promising, but there will continue to be volatility in the market.

Over the long term, I expect the countries will come to a mutually beneficial agreement.

Should you invest?

Bellamy's shares currently trade at 20x earnings, which is above the market average of 16/17x earnings. This is rather modest when compared to A2 Milk, whose shares currently trade at 42x earnings. The company expects FY19 EBITDA margins of 22-25%, in line with FY18.

The Chinese organic baby formula market has grown formal retail sales at a compound annual growth rate of 35% between FY13 and FY17. This tailwind should support Bellamy's business going forward.

Given the relatively modest valuation and strong growth prospects of the company, long-term investors should see Bellamy's as a strong candidate for their portfolio.

Motley Fool contributor Lloyd Prout has no position in any of the stocks mentioned and expresses his own opinion. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Happy wife holding her hands on her husband's shoulders while both look at a laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man stands in front of a chart with an arrow going down and slaps his forehead in frustration.
ASX Share Market News

ASX 200 mining shares smashed in major market sell-off

The ASX 200 fell 5.39% amid a mining sell-off, with BHP shares tumbling almost 13% last week.

Read more »

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »